Skip to main content
$9.26 +0.14 (+1.54%)
Market Cap
$509.86M
Shares
55.91M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Mark Newcomer $2,754,265
Matthew Turner $1,542,526
Michael Ngo $1,489,712
Fiscal 2024
Executive Total
Mark Newcomer $1,347,558
Robert P. Strobo $699,042
Jeffery B. Baker $697,557
Patient Affordability $539,517
Michael Ngo
Fiscal 2023
Executive Total
Mark Newcomer $1,207,659
Robert P. Strobo $574,652
Jeffery B. Baker $572,017
Fiscal 2022
Executive Total
Mark Newcomer $2,518,237
Robert P. Strobo $1,140,202
Jeffery B. Baker $1,138,618
Fiscal 2021
Executive Total
Jeffery B. Baker $1,911,545
Mark Newcomer $963,341
Mark Attinger $565,659
Robert P. Strobo $383,360
Fiscal 2020
Executive Total
Mark Newcomer $1,037,036
Mark Attinger $790,078
Daniel H. Spence $663,036
Robert P. Strobo $517,206
Fiscal 2019
Executive Total
Mark Newcomer $1,031,969
Daniel H. Spence $663,036
Mark Attinger $647,088
Key facts CIK 1496443 CUSIP 70451A104 13F (30d) 19 filings 19 filers Visit website